NCT06278103 2024-02-26
MethylRH-M
Central Hospital, Nancy, France
Unknown
Clinical Trials
16 trialsNCT01166321 2024-01-05
MARCIE
University Hospital Heidelberg
Phase NA Unknown
NCT04372095 2023-10-30
ANDROMEDE-F
Assistance Publique - Hôpitaux de Paris
Unknown
NCT04635657 2023-10-24
Cognitive Status After Removal of Skull Base Meningioma
Ohio State University
Unknown
NCT04367779 2023-09-13
PROTONBIOMARKS
Centre Leon Berard
Unknown
NCT04712214 2023-04-25
Use of Non-invasive Optical Analysis in Neurosurgery
Imperial College London
Phase NA Unknown
NCT05821790 2023-04-20
MEME
Assistance Publique - Hôpitaux de Paris
Unknown
NCT03071874 2022-10-18
Vistusertib (AZD2014) For Recurrent Grade II-III Meningiomas
Massachusetts General Hospital
Phase 2 Unknown
NCT05230381 2022-08-29
Intravenous Tranexamic Acid Reducing Intraoperative Blood Loss in Huge Meningiomas Resection
Beijing Tiantan Hospital
Phase NA Unknown
NCT02973256 2022-04-14
ATYPICMENING
University Hospital, Montpellier
Unknown
NCT04728568 2021-08-10
Exploratory Study of PD-1 Neoadjuvant Treatment of Recurrent Meningioma
Beijing Tiantan Hospital
Phase NA Unknown
NCT02974127 2021-02-21
MuRaLM
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Unknown
NCT04386642 2021-01-27
Tranexamic Acid Reduce Blood Loss in Meningioma Resection
Chiang Mai University
Phase 4 Unknown
NCT04710485 2021-01-14
Sphenoorbital Meningioma Management.
Assiut University
Unknown
NCT01849484 2016-08-01
HIPPO-SPARE 01
University of Erlangen-Nürnberg Medical School
Phase 2 Unknown
NCT01655927 2012-08-02
COLFIRE
Colombian Foundation for Epilepsy and Neurological Disease
Phase 3 Unknown